Cross Country Healthcare (CCRN) Common Equity (2010 - 2026)

Cross Country Healthcare has reported Common Equity for 17 years, with the latest figure at $312.8 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 25.2% year-over-year to $312.8 million; the trailing twelve-month figure through Mar 2026 stood at $312.8 million (down 25.2% YoY), and the FY2025 full-year result was $322.8 million, down 22.95% from the prior year.
• Common Equity for Q1 2026 stood at $312.8 million, down from $322.8 million in the prior quarter.
• The five-year high for Common Equity was $467.7 million in Q4 2023, with the low at $312.8 million in Q1 2026.
• Historically, Common Equity has averaged $417.8 million across 5 years, with a median of $422.7 million in 2022.
• Annual changes were most pronounced in 2022 — Common Equity jumped 113.82% — and 2026, when it slipped 25.2%.
• Cross Country Healthcare's Common Equity stood at $451.5 million in 2022, then climbed by 3.58% to $467.7 million in 2023, then fell by 10.41% to $419.0 million in 2024, then retreated by 22.95% to $322.8 million in 2025, then retreated by 3.1% to $312.8 million in 2026.
• The last three Common Equity figures came in at $312.8 million (Q1 2026), $322.8 million (Q4 2025), and $408.1 million (Q3 2025), per Business Quant data.